Emergence of vancomycin resistant Staphylococcus aureus(VRSA) from a tertiary care hospital from northern part of India
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lowy FD: Staphylococcus aureus infections. New Engl J Med. 1998, 339: 520-532. 10.1056/NEJM199808203390806.
Chambers HF: Methicillin resistance in Staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 1997, 10: 781-791.
Brumfil W, Hamilton-Miller J: Methicillin resistant Staphylococcus aureus. N Engl J Med. 1989, 320: 1188-1196.
Ena J, Dick RW, Jones RN, Wenzel RP: The epidemiology of intravenous vacomycin usage in a university hospital: a 10 year study. JAMA. 1993, 269: 598-602. 10.1001/jama.269.5.598.
Tenover FC, Biddle JW, Lancaster MV: Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Inf Dis. 2001, 7: 327-332.
Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC: Methicillin resistant Staphylococcus aureus clinicalstrain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997, 40: 135-136. 10.1093/jac/40.1.135.
Centers for Disease Control and Prevention: Staphylococcus aureus with reduced susceptibility to vancomycin United States, 1997. Morb Mortal Wkly Rep MMWR. 1997, 46: 765-766.
Centers for Disease Control and Prevention: Staphylococcus aureus resistant to vancomycin – United States, 2002. Morb Mortal Wkly Rep MMWR. 2002, 51: 565-567.
Palazzo ICV, Araujo MLC, Darini ALC: First Report of Vancomycin-Resistant Staphylococci Isolated from Healthy Carriers in Brazil. J Clin Microbiol. 2005, 43: 179-185. 10.1128/JCM.43.1.179-185.2005.
Bataineh AB: Resistance of Staphylococcus aureus to Vancomycin in Zarqa, Jordan. Pak J Med Sci. 2006, 22: 144-148.
Smith TL, Pearson LM, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR: Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. 1999, 340: 493-501. 10.1056/NEJM199902183400701.
Rotun SS, McMath V, Schoonmaker DJ, Maupin PS, Tenover FC, Hill BC, Ackman DM: Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis. 1999, 5: 147-149.
Centers for Disease Control and Prevention: Staphylococcus aureus with reduced susceptibility to vancomycin-Illinois, 1999. Morb Mortal Wkly Rep MMWR. 2000, 48: 1165-1167.
Ploy MC, Grelaud C, Martin C, de Lumley L, Denis F: Firstclinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet. 1998, 351: 1212-10.1016/S0140-6736(05)79166-2.
Howe RA, Bowker KE, Walsh TR, Feest TG, MacGowan AP: Vancomycin-resistant Staphylococcus aureus. Lancet. 1998, 351: 602-10.1016/S0140-6736(05)78597-4.
Bierbaum G, Fuchs K, Lenz W, Szekat C, Sahl HG: Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis. 1999, 18: 691-696. 10.1007/s100960050380.
Assadullah S, Kakru DK, Thoker MA, Bhat FA, Hussain N, Shah A: Emergence of low level vancomycin resistance in MRSA. Indian J Med Microbiol. 2003, 21: 196-198.
Baird D: Staphylococcus: cluster forming gram positive cocci. Mackie and McCartney Practical Medical Microbiology. Edited by: Collee JG, Fraser AG, Marmion BP, Simmons A. 1996, New York; Churchill Livingstone, 245-261. 14
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A5. NCCLS. 2000, Wayne, PA, USA, 5
Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: a Laboratory Manual. 1982, Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Geha DJ, Uhl JR, Gustaferro CA, Persing DH: Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory. J Clin Microbiol. 1994, 32: 1768-1772.
Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC: Characterization of glycopeptide-resistant enterococci from U. S. hospitals. Antimicob Agents Chemother. 1993, 37: 2311-2317.
Song JH, Hiramatsu K, Suh JY, Ko KS, Ito T, Kapi M, Kiem S, Kim YS, Oh WS, Peck KR, Lee NY, Asian Network for Surveillance of Resistant Pathogens Study Group: Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother. 2004, 48: 4926-4928. 10.1128/AAC.48.12.4926-4928.2004.
Holloway K: Antimicrobial resistance: the facts. Essential Drug Monitor WHO. 2000, 28&29: 7-8.
Noble WC, Virani Z, Cree RC: Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992, 72: 195-198. 10.1111/j.1574-6968.1992.tb05089.x.
Showsh SA, De Boever RH, Clewell DB: Vancomycin resistance plasmid in Enterococcus faecalis that encodes sensitivity to a sex pheromone also produced by Staphylococcus aureus. Antimicrob Agents Chemother. 2001, 45: 2177-2178. 10.1128/AAC.45.7.2177-2178.2001.
Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, H Labischinski H, Hiramatsu K: Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother. 1998, 42: 199-209. 10.1093/jac/42.2.199.
Hanaki H, Labischinski H, Inaba Y, Kondo N, Murakami H, Hiramatsu K: Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. J Antimicrob Chemother. 1998, 42: 315-320. 10.1093/jac/42.3.315.
Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K: Contribution of a thickened cell wall and its gultamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. J Antimicrob Chemother. 2000, 44: 2276-2285. 10.1128/AAC.44.9.2276-2285.2000.
Marchese A, Balistreri G, Tonoli E, Debbia EA, Schito GC: Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol. 2000, 38: 866-869.
Rotun SS, McMath V, Schoonmaker DJ, Maupin PS, Tenover FC, Hill BC, Ackman DM: Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis. 1999, 5: 147-149.